The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Response to epidermal growth factor vaccine in patients with metastatic non-small cell lung cancer (NSCLC) after progressing to first-line therapy.
Diego Venegas
Other Remuneration - Quality Pharma
Elia Neninger
No relevant relationships to disclose
Carlos Iberico
No relevant relationships to disclose
Claudia Oliva
No relevant relationships to disclose
Ashley E. Alarcon-Rozas
No relevant relationships to disclose
Claudia Patricia Lozada
No relevant relationships to disclose
Jose Galvez
No relevant relationships to disclose
Gisela Gonzalez
Employment or Leadership Position - CIMAB S.A.